Literature DB >> 15755491

Expression of multiple CaV1.2 transcripts in rat tissues mediated by different promoters.

Nehad I Saada1, Elba D Carrillo, Bosong Dai, Wen-Ze Wang, Christine Dettbarn, Jorge Sanchez, Philip Palade.   

Abstract

The expression of two different transcripts for Ca(V)1.2 in rat tissues mirrors that which has previously been described for human tissue, in that expression of transcripts expressing exon 1a is predominant only in heart, whereas expression of transcripts expressing exon 1b is greater in smooth muscle rich tissues such as aorta and intestine. Transcripts expressing exon 1b also predominate in brain and in diaphragm. Western blots indicate that the N-terminus coded for by exon 1b is present in much of the protein in all these tissues except heart. The promoter just upstream of exon 1b has been cloned, sequenced and utilized to drive expression of luciferase in smooth muscle A7r5 cells, cardiac HL-1 cells, skeletal muscle L6 cells and neuronal PC12 cells. The nucleotide sequence of the promoter exhibits 80% identity with the equivalent promoter previously identified in humans and 94% identity with the sequence of the equivalent region of the mouse genome. Evidence in favor of still another promoter upstream of exon 2 has been uncovered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755491     DOI: 10.1016/j.ceca.2004.11.003

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  15 in total

Review 1.  Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications.

Authors:  Swapnil Sonkusare; Philip T Palade; James D Marsh; Sabine Telemaque; Aleksandra Pesic; Nancy J Rusch
Journal:  Vascul Pharmacol       Date:  2006-01-20       Impact factor: 5.773

2.  Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel.

Authors:  Swapnil Sonkusare; Mony Fraer; James D Marsh; Nancy J Rusch
Journal:  Mol Interv       Date:  2006-12

3.  Vascular smooth muscle-specific knockdown of the noncardiac form of the L-type calcium channel by microRNA-based short hairpin RNA as a potential antihypertensive therapy.

Authors:  Sung W Rhee; Joseph R Stimers; Wenze Wang; Li Pang
Journal:  J Pharmacol Exp Ther       Date:  2009-02-24       Impact factor: 4.030

4.  Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins.

Authors:  Zhen Zhi Tang; Sika Zheng; Julia Nikolic; Douglas L Black
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

5.  The voltage-dependent L-type Ca2+ (CaV1.2) channel C-terminus fragment is a bi-modal vasodilator.

Authors:  John P Bannister; Marie Dennis Leo; Damodaran Narayanan; Wanchana Jangsangthong; Anitha Nair; Kirk W Evanson; Judith Pachuau; Kyle S Gabrick; Frederick A Boop; Jonathan H Jaggar
Journal:  J Physiol       Date:  2013-04-08       Impact factor: 5.182

Review 6.  Autoregulation of cardiac l-type calcium channels.

Authors:  Jonathan Satin; Elizabeth A Schroder
Journal:  Trends Cardiovasc Med       Date:  2009-11       Impact factor: 6.677

7.  Alternative Splicing at N Terminus and Domain I Modulates CaV1.2 Inactivation and Surface Expression.

Authors:  Peter Bartels; Dejie Yu; Hua Huang; Zhenyu Hu; Stefan Herzig; Tuck Wah Soong
Journal:  Biophys J       Date:  2018-05-08       Impact factor: 4.033

8.  Modulation of distinct isoforms of L-type calcium channels by G(q)-coupled receptors in Xenopus oocytes: antagonistic effects of Gβγ and protein kinase C.

Authors:  Sharon Weiss; Tal Keren-Raifman; Shimrit Oz; Adva Ben Mocha; Hannelore Haase; Nathan Dascal
Journal:  Channels (Austin)       Date:  2012-09-18       Impact factor: 2.581

Review 9.  Calcium Channel CaVα₁ Splice Isoforms - Tissue Specificity and Drug Action.

Authors:  Diane Lipscombe; Arturo Andrade
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

10.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.